Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol

Helen Craige; Jack B. Cohen

doi:10.1016/j.jaad.2005.07.021

Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol

Helen Craige, Jack B. Cohen

Research output: Contribution to journal › Article

31 Scopus citations

Abstract

Flushing has been associated with medications, rosacea, menopause, carcinoid syndrome, pheochromocytoma, polycythemia, and mastocytosis, although it can occur without known cause. There are no known specific treatments available, but β-blockers have suppressed flushing reactions in some patients, particularly when associated with anxiety. The medical histories and clinical characteristics of 9 patients with either idiopathic flushing or flushing associated with rosacea were reviewed. Eight patients experienced subjective improvement with propranolol therapy.

Original language	English (US)
Pages (from-to)	881-884
Number of pages	4
Journal	Journal of the American Academy of Dermatology
Volume	53
Issue number	5
DOIs	https://doi.org/10.1016/j.jaad.2005.07.021
State	Published - Nov 1 2005

ASJC Scopus subject areas

Dermatology

Access to Document

10.1016/j.jaad.2005.07.021

Fingerprint Dive into the research topics of 'Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol'. Together they form a unique fingerprint.

Cite this

Craige, H., & Cohen, J. B. (2005). Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol. Journal of the American Academy of Dermatology, 53(5), 881-884. https://doi.org/10.1016/j.jaad.2005.07.021

@article{f586123c3af54dd6acb28edc1ec296ac,

title = "Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol",

abstract = "Flushing has been associated with medications, rosacea, menopause, carcinoid syndrome, pheochromocytoma, polycythemia, and mastocytosis, although it can occur without known cause. There are no known specific treatments available, but β-blockers have suppressed flushing reactions in some patients, particularly when associated with anxiety. The medical histories and clinical characteristics of 9 patients with either idiopathic flushing or flushing associated with rosacea were reviewed. Eight patients experienced subjective improvement with propranolol therapy.",

author = "Helen Craige and Cohen, {Jack B.}",

year = "2005",

month = nov,

day = "1",

doi = "10.1016/j.jaad.2005.07.021",

language = "English (US)",

volume = "53",

pages = "881--884",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol

AU - Craige, Helen

AU - Cohen, Jack B.

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Flushing has been associated with medications, rosacea, menopause, carcinoid syndrome, pheochromocytoma, polycythemia, and mastocytosis, although it can occur without known cause. There are no known specific treatments available, but β-blockers have suppressed flushing reactions in some patients, particularly when associated with anxiety. The medical histories and clinical characteristics of 9 patients with either idiopathic flushing or flushing associated with rosacea were reviewed. Eight patients experienced subjective improvement with propranolol therapy.

AB - Flushing has been associated with medications, rosacea, menopause, carcinoid syndrome, pheochromocytoma, polycythemia, and mastocytosis, although it can occur without known cause. There are no known specific treatments available, but β-blockers have suppressed flushing reactions in some patients, particularly when associated with anxiety. The medical histories and clinical characteristics of 9 patients with either idiopathic flushing or flushing associated with rosacea were reviewed. Eight patients experienced subjective improvement with propranolol therapy.

UR - http://www.scopus.com/inward/record.url?scp=27144559453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144559453&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2005.07.021

DO - 10.1016/j.jaad.2005.07.021

M3 - Article

C2 - 16243148

AN - SCOPUS:27144559453

VL - 53

SP - 881

EP - 884

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 5

ER -